Skip to main content
. 2011 Oct;17(10):1917–1920. doi: 10.3201/eid1710.101365

Table 2. Bacitracin and neomycin susceptibility of MRSA USA300 and other MRSA isolates*.

Bacitracin/neomycin
MRSA USA300 (MICs of bacitracin, neomycin, and polymyxin B)† Other MRSA
Kyoto University Hospital
Nagoya Medical Center
ATCC type strains
R/R 9 (400, 128, 200–400) 0 BAA1717 (400, 128, 400) 0
R/S 0 1 (400, 0.25, 400) 0
S/R 0 0 11
I/S 0 0 1
S/I 0 0 132
S/S
9 (6.25–12.5, 0.25, 400)
0
BAA1556 (6.25, 0.25, 400)
96
Total 18 1 2 240

*MRSA, methicillin resistant Staphylococcus aureus; ATCC, American Type Culture Collection (Manassas, VA, USA); R, resistant; S, susceptible; I, intermediate resistance.
†MICs are expressed as units/mL for bacitracin and polymyxin B and in μg/mL for neomycin.